Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew W Boyd

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
Neuroscience Letters|July 25, 2012
Partial change in EphA4 knockout mouse phenotype: loss of diminished GFAP upregulation following spinal cord injuryKirsty J Dixon, Kathryn M Munro, Andrew W Boyd, et al.
BMJ Open|April 25, 2014
Validating childhood asthma in an epidemiological study using linked electronic patient recordsRosaleen P Cornish, John Henderson, Andrew W Boyd, et al.
Gene Expression Patterns : GEP|March 8, 2005
Cloning and expression of the large zebrafish protocadherin gene, FatMichelle Down, Maryanne Power, Shirley I Smith, et al.
Growth Factors (Chur, Switzerland)|November 21, 2014
Eph family co-expression patterns define unique clusters predictive of cancer phenotypeFares Al-Ejeh, Carolin Offenhäuser, Yi Chieh Lim, et al.
Stem Cells (Dayton, Ohio)|April 1, 2006
Gene expression profiles in murine hematopoietic stem cells revisited: analysis of cDNA libraries reveals high levels of translational and metabolic activitiesAndreas Hüttmann, Ulrich Dührsen, Katja Heydarian, et al.
European Journal of Cancer (Oxford, England : 1990)|August 20, 2011
Complex expression patterns of Eph receptor tyrosine kinases and their ephrin ligands in colorectal carcinogenesisNirmitha I Herath, Mark D Spanevello, James D Doecke, et al.
Clinical Drug Investigation|December 2, 2024
Evaluation of NUN-004, a Novel Engineered Ephrin Antagonist, in Healthy Volunteers and Patients with Amyotrophic Lateral Sclerosis: A Phase I/Ib, Open-Label, Escalating Dose and Extended Access StudyMichael Gerometta, Robert D Henderson, Richard Friend, et al.
The Journal of Biological Chemistry|May 20, 2005
Three distinct molecular surfaces in ephrin-A5 are essential for a functional interaction with EphA3Bryan Day, Catherine To, Juha-Pekka Himanen, et al.
Science Translational Medicine|April 24, 2024
Inhibiting Eph/ephrin signaling reduces vascular leak and endothelial cell dysfunction in mice with sepsisNemat Khan, Vinod Kumar, Pengcheng Li, et al.
Brain Research. Developmental Brain Research|April 30, 2002
EphA4 is not required for Purkinje cell compartmentationSana D Karam, Mirella Dottori, Kazushige Ogawa, et al.
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Neuroscience Letters|July 25, 2012
Partial change in EphA4 knockout mouse phenotype: loss of diminished GFAP upregulation following spinal cord injuryKirsty J Dixon, Kathryn M Munro, Andrew W Boyd, et al.
BMJ Open|April 25, 2014
Validating childhood asthma in an epidemiological study using linked electronic patient recordsRosaleen P Cornish, John Henderson, Andrew W Boyd, et al.
Gene Expression Patterns : GEP|March 8, 2005
Cloning and expression of the large zebrafish protocadherin gene, FatMichelle Down, Maryanne Power, Shirley I Smith, et al.
Growth Factors (Chur, Switzerland)|November 21, 2014
Eph family co-expression patterns define unique clusters predictive of cancer phenotypeFares Al-Ejeh, Carolin Offenhäuser, Yi Chieh Lim, et al.
Stem Cells (Dayton, Ohio)|April 1, 2006
Gene expression profiles in murine hematopoietic stem cells revisited: analysis of cDNA libraries reveals high levels of translational and metabolic activitiesAndreas Hüttmann, Ulrich Dührsen, Katja Heydarian, et al.
European Journal of Cancer (Oxford, England : 1990)|August 20, 2011
Complex expression patterns of Eph receptor tyrosine kinases and their ephrin ligands in colorectal carcinogenesisNirmitha I Herath, Mark D Spanevello, James D Doecke, et al.
Clinical Drug Investigation|December 2, 2024
Evaluation of NUN-004, a Novel Engineered Ephrin Antagonist, in Healthy Volunteers and Patients with Amyotrophic Lateral Sclerosis: A Phase I/Ib, Open-Label, Escalating Dose and Extended Access StudyMichael Gerometta, Robert D Henderson, Richard Friend, et al.
The Journal of Biological Chemistry|May 20, 2005
Three distinct molecular surfaces in ephrin-A5 are essential for a functional interaction with EphA3Bryan Day, Catherine To, Juha-Pekka Himanen, et al.
Science Translational Medicine|April 24, 2024
Inhibiting Eph/ephrin signaling reduces vascular leak and endothelial cell dysfunction in mice with sepsisNemat Khan, Vinod Kumar, Pengcheng Li, et al.
Brain Research. Developmental Brain Research|April 30, 2002
EphA4 is not required for Purkinje cell compartmentationSana D Karam, Mirella Dottori, Kazushige Ogawa, et al.
Pageof 7